SG Americas Securities’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

SG Americas Securities’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,333	Closed	-$36K	–	3601
2019 Q1	$36K	Sell	1,333 -1,732	-57%	-$44.1K	﹤0.01%	3238
2018 Q4	$69K	Buy	+3,065	New	+$120K	﹤0.01%	2786
2018 Q2	–	Sell	-523	Closed	-$32K	–	3639
2018 Q1	$32K	Sell	523 -46	-8%	-$4.04K	﹤0.01%	3125
2017 Q4	$72K	Sell	569 -211	-27%	-$27K	﹤0.01%	2919
2017 Q3	$107K	Buy	+780	New	+$104K	﹤0.01%	3155
2016 Q4	–	Sell	-1,320	Closed	-$101K	–	3601
2016 Q3	$101K	Buy	+1,320	New	+$106K	﹤0.01%	3072
2015 Q4	–	Sell	-1,293	Closed	-$193K	–	3083
2015 Q3	$193K	Buy	+1,293	New	+$949K	﹤0.01%	1487
2015 Q2	–	Sell	-522	Closed	-$383K	–	2929
2015 Q1	$383K	Buy	522 +158	+43%	+$119K	﹤0.01%	1564
2014 Q4	$289K	Buy	+364	New	+$196K	﹤0.01%	2109

Other funds holding TTPH

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

SG Americas Securities's TTPH Position: Q2 2019 in Review

SG Americas Securities sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q2 2019, closing a stake of 1,333 shares — an estimated $36K sold.

SG Americas Securities first reported a position in TTPH in Q4 2014 and held it in 9 quarters. The position peaked at $383K in Q1 2015. 66 funds tracked by Wall St. Rank hold TTPH as of Q2 2019.

SG Americas Securities reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
SG Americas Securities sold 1,333 Tetraphase Pharmaceuticals, Inc. shares in Q2 2019, an estimated $36K.
SG Americas Securities first reported a position in Tetraphase Pharmaceuticals, Inc. in Q4 2014 and held it in 9 quarters.
SG Americas Securities's Tetraphase Pharmaceuticals, Inc. position peaked at $383K in Q1 2015.
66 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q2 2019.

Based on SG Americas Securities's 13F filing for Q2 2019, filed 29 Jul 2019.